-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Caribou Biosciences, Lowers Price Target to $3

Benzinga·04/28/2025 17:52:40
Listen to the news
HC Wainwright & Co. analyst Robert Burns maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and lowers the price target from $9 to $3.